SX-682,Nivolumab
Syntrix,BMS
['rectal', 'colorectal']
read the #aacr23 abstract for the phase i/ii trial looking at combination of cxcr1/2 inhibitor with anti-pd-1 for ctdna positive &amp; refractory ras-mutated microsatellite stable (mss) colorectal cancer: #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789